Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 7/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | DPP4 | P27487 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MITF | O75030 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | NLRP1 | Q9C000 | 1/20 | 0.36 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10660120 | 0.97 | EPHX1 (0.61) | EPHX1ALDH1A1DPP4SMN1; SMN2CYP3A4 | |
| SCHEMBL17316191 | 0.97 | EPHX1 (0.61) | EPHX1ALDH1A1DPP4SMN1; SMN2CYP3A4 | |
| SCHEMBL66996 | 0.97 | EPHX1 (0.61) | EPHX1ALDH1A1DPP4SMN1; SMN2CYP3A4 | |
| SCHEMBL849367 | 0.88 | EPHX1 (0.42) | EPHX1ALDH1A1MAPTMEN1LMNA | |
| SCHEMBL4454833 | 0.79 | EPHX1 (0.48) | EPHX1ALDH1A1DPP4SMN1; SMN2CYP3A4 | |
| SCHEMBL30093936 | 0.77 | EPHX1 (0.44) | EPHX1ALDH1A1DPP4SMN1; SMN2CYP3A4 | |
| SCHEMBL4611368 | 0.77 | EPHX1 (0.44) | EPHX1ALDH1A1DPP4SMN1; SMN2CYP3A4 | |
| SCHEMBL11197502 | 0.77 | EPHX1 (0.64) | EPHX1ALDH1A1DPP4SMN1; SMN2CYP3A4 | |
| SCHEMBL2848891 | 0.77 | EPHX1 (0.56) | EPHX1ALDH1A1DPP4SMN1; SMN2CYP3A4 | |
| SCHEMBL28704681 | 0.76 | EPHX1 (0.39) | EPHX1DPP4CPB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217204-B2 | Catalyst for asymmetric hydrogenation | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-07-10 | — | — | US | claimed |
| EP-0209621-B1 | AN IMMERSION OIL FOR MICROSCOPE | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1990-05-09 | — | — | EP | claimed |
| US-4789490-A | LIQUID DIENIC POLYMER; CONTROLLED SPECIFIC GRAVITY AND ABBE NUMBER | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1988-12-06 | — | — | US | claimed |
| EP-0209621-A2 | An immersion oil for microscope | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1987-01-28 | — | — | EP | claimed |
| CN-115385820-A | Cationic lipids and uses thereof | 英维沃生物科技(苏州)有限公司 | 2022-11-25 | — | — | CN | disclosed |
| EP-2438989-B1 | USE OF ASYMMETRIC HYDROGENATION CATALYST | TAKASAGO PERFUMERY CO LTD (JP) | 2016-04-13 | — | — | EP | disclosed |
| US-9061959-B2 | Method for manufacturing optically active menthol | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-06-23 | — | — | US | disclosed |
| US-9000192-B2 | Catalyst for asymmetric hydrogenation and method for manufacturing optically active carbonyl compound using the same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2015-04-07 | — | — | US | disclosed |
| EP-2646150-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | Takasago International Corporation (JP) | 2013-10-09 | — | — | EP | disclosed |
| EP-2647616-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | Takasago International Corporation (JP) | 2013-10-09 | — | — | EP | disclosed |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-09-26 | — | — | US | disclosed |
| US-20130217895-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2013-08-22 | — | — | US | disclosed |
| WO-2000064940-A1 | INSULIN CRYSTALS FOR PULMONARY ADMINISTRATION | ELI LILLY AND COMPANY (US) | 2000-11-02 | — | — | WO | disclosed |
| WO-1999032116-A1 | INSOLUBLE COMPOSITIONS FOR CONTROLLING BLOOD GLUCOSE | ELI LILLY AND COMPANY (US) | 1999-07-01 | — | — | WO | disclosed |
| EP-0925792-A2 | Insoluble compositions for controlling blood glucose | ELI LILLY AND COMPANY (US) | 1999-06-30 | — | — | EP | disclosed |
| WO-1999021578-A1 | INSOLUBLE INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 1999-05-06 | — | — | WO | disclosed |
| EP-0911035-A2 | INSOLUBLE INSULIN COMPOSITIONS | ELI LILLY AND COMPANY (US) | 1999-04-28 | — | — | EP | disclosed |
| EP-0209621-B1 | AN IMMERSION OIL FOR MICROSCOPE | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1990-05-09 | — | — | EP | disclosed |
| US-4789490-A | LIQUID DIENIC POLYMER; CONTROLLED SPECIFIC GRAVITY AND ABBE NUMBER | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 1988-12-06 | — | — | US | disclosed |
| EP-0209621-A2 | An immersion oil for microscope | IDEMITSU PETROCHEMICAL CO. LTD. (JP) | 1987-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130217895-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION AND METHOD FOR MANUFACTURING OPTICALLY ACTIVE CARBONYL COMPOUND USING THE SAME | HMOX1, NQO1, CBR3 | EPHX1 931/4885ALDH1A1 61/4885DPP4 4720/4885 |
| US-20130253228-A1 | METHOD FOR MANUFACTURING OPTICALLY ACTIVE MENTHOL | MSMO1, GGPS1, MAN1B1 | EPHX1 40/4885ALDH1A1 79/4885DPP4 3902/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.